Literature DB >> 8317898

Effect of dietary fat and cholesterol on dimethylbenz[a]-anthracene-induced mammary tumorigenesis in Sprague-Dawley rats.

M Nakayama1, H R Ju, M Sugano, N Hirose, T Ueki, F Doi, A R Eynard.   

Abstract

The effect of dietary fats and cholesterol on dimethylbenz[a]-anthracene-induced mammary tumorigenesis was studied in female Sprague-Dawley rats. When the dietary fat source (at the 5% level) was palm oil (saturated fat) or corn oil (unsaturated fat), dietary cholesterol at the 0.2% level increased the tumor number of rats fed corn oil, but not those fed palm oil. Perilla oil (rich in alpha-linolenic acid) reduced tumor development as compared with safflower oil (rich in linoleic acid), but again dietary cholesterol at the 0.5% level diminished the favorable effect of n-3 polyunsaturated fatty acid (PUFA). The adverse effect of cholesterol was also observed in the n-6 PUFA fat. The promotive effect of dietary cholesterol was not necessarily associated with the change in the production of prostaglandin E2 by the tumor tissue or in the immunopotentiation. These results at least stress that the contrasting effects of dietary fats should be carefully evaluated whether cholesterol is present simultaneously or not.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8317898

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  2 in total

1.  Synergistic anticancer effects of combined γ-tocotrienol with statin or receptor tyrosine kinase inhibitor treatment.

Authors:  Paul W Sylvester
Journal:  Genes Nutr       Date:  2011-05-01       Impact factor: 5.523

2.  Nongenotoxic effects and a reduction of the DXR-induced genotoxic effects of Helianthus annuus Linné (sunflower) seeds revealed by micronucleus assays in mouse bone marrow.

Authors:  Marcelo Fabiano Gomes Boriollo; Luiz Silva Souza; Marielly Reis Resende; Thaísla Andrielle da Silva; Nelma de Mello Silva Oliveira; Maria Cristina Costa Resck; Carlos Tadeu dos Santos Dias; João Evangelista Fiorini
Journal:  BMC Complement Altern Med       Date:  2014-04-02       Impact factor: 3.659

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.